JP2016503066A - 酢酸グラチラマーの経口経粘膜送達 - Google Patents

酢酸グラチラマーの経口経粘膜送達 Download PDF

Info

Publication number
JP2016503066A
JP2016503066A JP2015549794A JP2015549794A JP2016503066A JP 2016503066 A JP2016503066 A JP 2016503066A JP 2015549794 A JP2015549794 A JP 2015549794A JP 2015549794 A JP2015549794 A JP 2015549794A JP 2016503066 A JP2016503066 A JP 2016503066A
Authority
JP
Japan
Prior art keywords
film composition
weight percent
amount
present
film
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2015549794A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016503066A5 (cg-RX-API-DMAC7.html
Inventor
ゲイスター、ウルスラ
シュバイツァー、ステファン
ベルガー、マルティナ
ステファン、ラルフ
フーバー、ジェラルド
プリーズ、タンヤ
Original Assignee
テバ ファーマシューティカル インダストリーズ リミティド
テバ ファーマシューティカル インダストリーズ リミティド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by テバ ファーマシューティカル インダストリーズ リミティド, テバ ファーマシューティカル インダストリーズ リミティド filed Critical テバ ファーマシューティカル インダストリーズ リミティド
Publication of JP2016503066A publication Critical patent/JP2016503066A/ja
Publication of JP2016503066A5 publication Critical patent/JP2016503066A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2015549794A 2012-12-21 2013-12-20 酢酸グラチラマーの経口経粘膜送達 Withdrawn JP2016503066A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261745243P 2012-12-21 2012-12-21
US61/745,243 2012-12-21
PCT/US2013/077041 WO2014100643A1 (en) 2012-12-21 2013-12-20 Oral transmucosal delivery of glatiramer acetate

Publications (2)

Publication Number Publication Date
JP2016503066A true JP2016503066A (ja) 2016-02-01
JP2016503066A5 JP2016503066A5 (cg-RX-API-DMAC7.html) 2017-02-02

Family

ID=50979258

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015549794A Withdrawn JP2016503066A (ja) 2012-12-21 2013-12-20 酢酸グラチラマーの経口経粘膜送達

Country Status (15)

Country Link
US (1) US20150328277A1 (cg-RX-API-DMAC7.html)
EP (1) EP2934493A4 (cg-RX-API-DMAC7.html)
JP (1) JP2016503066A (cg-RX-API-DMAC7.html)
KR (1) KR20150111919A (cg-RX-API-DMAC7.html)
CN (1) CN104869984A (cg-RX-API-DMAC7.html)
AU (1) AU2013361057A1 (cg-RX-API-DMAC7.html)
BR (1) BR112015014092A2 (cg-RX-API-DMAC7.html)
CA (1) CA2895457A1 (cg-RX-API-DMAC7.html)
EA (1) EA201591187A1 (cg-RX-API-DMAC7.html)
HK (2) HK1214522A1 (cg-RX-API-DMAC7.html)
IL (1) IL239279A0 (cg-RX-API-DMAC7.html)
MX (1) MX2015007794A (cg-RX-API-DMAC7.html)
SG (1) SG11201504461QA (cg-RX-API-DMAC7.html)
WO (1) WO2014100643A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201505050B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA025780B1 (ru) 2010-10-11 2017-01-30 Тева Фармасьютикал Индастриз Лтд. Цитокиновые биомаркеры в качестве биомаркеров, прогнозирующих клинический ответ на глатирамер ацетат
MX2014004309A (es) 2011-10-10 2015-07-06 Teva Pharma Polimorfismos de nucleotidos individuales utiles para predecir una respuesta clinica para el acetato de glatiramer.
UY35790A (es) 2013-10-21 2015-05-29 Teva Pharma Marcadores genéticos que predicen la respuesta al acetato de glatiramer
US10493122B2 (en) 2014-03-17 2019-12-03 Mapi Pharma Ltd. Sublingual delivery of glatiramer acetate
US10323289B2 (en) 2017-06-26 2019-06-18 Institut Pasteur Treatments to eliminate HIV reservoirs and reduce viral load

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0679002A (ja) * 1993-12-14 1994-03-22 Hisamitsu Pharmaceut Co Inc 経皮投与用パッチシステム
US6197331B1 (en) * 1997-07-24 2001-03-06 Perio Products Ltd. Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity
US7022663B2 (en) * 2000-02-18 2006-04-04 Yeda Research And Development Co., Ltd. Oral, nasal and pulmonary dosage formulations of copolymer 1
US20020077278A1 (en) * 2000-06-05 2002-06-20 Yong V. Wee Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
US20030175328A1 (en) * 2002-03-06 2003-09-18 Adi Shefer Patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients into the skin
NZ540318A (en) * 2002-10-31 2007-09-28 Umd Inc Therapeutic compositions for drug delivery to and through covering epithelia
EP2106790B1 (en) * 2004-03-12 2012-10-24 Biodel, Inc. Rapid acting drug delivery compositions
FI20041425A0 (fi) * 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
US20060205822A1 (en) * 2004-12-22 2006-09-14 Forest Laboratories, Inc. 1-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect
US20060210616A1 (en) * 2005-03-17 2006-09-21 Linder Barry J Therapeutic patch for ophthalmologic and cosmetic use
US20070021325A1 (en) * 2005-07-21 2007-01-25 Mediplex Corporation Drug formulation containing a solubilizer for enhancing solubility, absorption, and permeability
US20080027011A1 (en) * 2005-12-20 2008-01-31 Hassan Nached Homogeneous paste and gel formulations
KR100809404B1 (ko) * 2005-12-28 2008-03-05 (주)스피어테크 리포좀화 시킨 나노용매를 함유하는 경피흡수 점착시트형 화장료 조성물 및 제조방법
WO2007087188A2 (en) * 2006-01-20 2007-08-02 Merck & Co., Inc. Taste-masked tablets and granules
RU2436565C2 (ru) * 2006-02-17 2011-12-20 Новартис Аг Распадающиеся пероральные пленки
WO2008006226A1 (en) * 2006-07-14 2008-01-17 Wine, Harvey Transdermal formulations of synthetic cannabinoids and nano colloidal silica
AU2007329375A1 (en) * 2006-12-04 2008-06-12 The Board Of Trustees Of The University Of Illinois Compositions and methods to treat cancer with cupredoxins and CpG rich DNA
JP5177447B2 (ja) * 2007-06-07 2013-04-03 佐藤製薬株式会社 速溶性及び可撓性を有するフィルム製剤
WO2009005814A2 (en) * 2007-07-03 2009-01-08 Marchitto Kevin S Drug-delivery patch comprising a dissolvable layer and uses thereof
US20100278899A1 (en) * 2007-12-06 2010-11-04 Lintec Corporation Edible film

Also Published As

Publication number Publication date
WO2014100643A1 (en) 2014-06-26
ZA201505050B (en) 2016-10-26
CN104869984A (zh) 2015-08-26
SG11201504461QA (en) 2015-07-30
HK1214522A1 (zh) 2016-07-29
WO2014100643A8 (en) 2015-06-25
EP2934493A4 (en) 2016-09-07
HK1214133A1 (zh) 2016-07-22
EP2934493A1 (en) 2015-10-28
EA201591187A1 (ru) 2016-03-31
CA2895457A1 (en) 2014-06-26
US20150328277A1 (en) 2015-11-19
AU2013361057A1 (en) 2015-07-30
BR112015014092A2 (pt) 2017-07-11
KR20150111919A (ko) 2015-10-06
MX2015007794A (es) 2015-09-04
IL239279A0 (en) 2015-07-30

Similar Documents

Publication Publication Date Title
TWI905080B (zh) 含右美托咪啶(dexmedetomidine)之膜調配物及其製造方法
DK2793857T3 (en) PHARMACEUTICAL SUPPLY TECHNOLOGY
MX2009002041A (es) Formulaciones galenicas de aliskiren.
US20150328277A1 (en) Oral transmucosal delivery of glatiramer acetate
KR20140121394A (ko) 아캄프로세이트 제제, 그것의 사용 방법, 및 그것을 포함하는 조합
TW202228682A (zh) 使用右美托咪啶(dexmedetomidine)鹽酸鹽治療躁鬱症及精神病
AU2015289150A1 (en) Orodispersible film
JP2011502132A (ja) 改善された錠剤コーティング
CN120983628A (zh) 纤溶酶原激活物抑制剂1(pai-1)抑制剂和其用途
JP2016503803A (ja) 酢酸グラチラマーの経粘膜送達
WO2015195605A1 (en) Transmucosal delivery of glatiramer acetate by oral patches
EA020417B1 (ru) Композиции для лечения розацеи
CN107854609A (zh) 红参、麦冬、五味子组合物用于制备治疗抑郁症的药物的用途
CN110496129A (zh) 利拉利汀的抗肿瘤活性及其新用途
WO2005049053A1 (en) Composition comprising a magnesium compound and/or a magnesium saltfor improving sexual dysfunction
JP4921662B2 (ja) アミノエタンスルホン酸含有製剤
TW201202232A (en) Treatment of GIST with masitinib
CN114652732B (zh) 白头翁皂苷b4在制备治疗阳痿药物中的应用
US11045437B2 (en) Composition for improving brain function
CN101269212B (zh) 一种可吞咽的漱口液
JP2025529123A (ja) 急性ストレス障害を処置するための方法及び組成物
EA052489B1 (ru) Жидкая композиция ингибиторов фосфодиэстеразы типа 5 (pde-5), способ ее получения и ее применение для лечения эректильных дисфункций
JP2004043376A (ja) アンジオテンシン変換酵素阻害剤
WO2015138887A1 (en) Transmucosal delivery of laquinimod by oral patches
JP2000136143A (ja) 抗ストレス組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150909

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161214

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20161214

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20170210